Patents Assigned to AXOLTIS PHARMA
  • Use of peptide compounds for promoting survival, growth and cell differentiation
    Patent number: 12163154
    Abstract: The present invention relates to the use of peptide compounds for promoting survival and/or growth and/or differentiation of progenitor cells or stem cells.
    Type: Grant
    Filed: December 5, 2017
    Date of Patent: December 10, 2024
    Assignee: Axoltis Pharma
    Inventor: Stéphane Gobron
  • Process for the preparation of a dodecapeptide
    Patent number: 11377471
    Abstract: The invention concerns an improved process for the preparation of the dodecapeptide NX210 of SEQ ID NO: 1 in which the formation of side products is minimized.
    Type: Grant
    Filed: February 9, 2018
    Date of Patent: July 5, 2022
    Assignee: AXOLTIS PHARMA
    Inventors: Stéphane Gobron, Dominique Bridon, Frédéric Cabart, Christian Fauster
  • Cyclic polypeptides, method for obtaining them and the therapeutic use thereof
    Patent number: 10501497
    Abstract: The invention relates to a polypeptide #including the following amino acid sequence: W-S-X1-W-X2-X3-C-S-X4-C-G (SEQ ID NO: 59), wherein X1, X2 and X3 are, independently of one another, S or G, X4 is R-S or V-S or V-T or R-T, and both cysteines form a disulfide bridge.
    Type: Grant
    Filed: September 23, 2016
    Date of Patent: December 10, 2019
    Assignee: AXOLTIS PHARMA
    Inventors: Dominique Bridon, Stéphane Gobron